IMPROVATE Revenue and Competitors
Employee Data
- IMPROVATE has 27 Employees.
- IMPROVATE grew their employee count by 13% last year.
IMPROVATE's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO&Co-founder | Reveal Email/Phone |
2 | VP Marketing | Reveal Email/Phone |
3 | VP Sales and Business Development | Reveal Email/Phone |
4 | Regional Sales Director - Homeland Security | Land Division | Reveal Email/Phone |
5 | Director Business Development | Reveal Email/Phone |
6 | Strategic Account Manager | Reveal Email/Phone |
IMPROVATE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 27 | 13% | N/A | N/A |
#2 | N/A | 2 | -33% | N/A | N/A |
What Is IMPROVATE?
IMPROVATE is a platform for Tech-enabled transformative innovation on a global scale. We connect - Changemakers to technology - Enterprise with policymakers - World leaders in Government and politics
keywords:N/AN/A
Total Funding
27
Number of Employees
N/A
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IMPROVATE News
2022-04-19 - Andrei Baciu, Secretary of State and the Ministry of Health of ...
IMPROVATE held two-day medical innovation and networking conference in Budapest, sparking groundbreaking deals between European representatives...
2022-04-19 - IMPROVATE held two-day medical innovation and networking conference in
Budapest, sparking groundbreaking deals between European representatives
and leading Israeli medical technology companies
IMPROVATE founder Irina Nevzlin: "IMPROVATE works across a diverse range of fields including cyber, HLS, and food and water-tech,...
2022-04-19 - Yacov Geva. President and CEO, G Medical Innovations and ...
Yacov Geva. President and CEO, G Medical Innovations and Rosen Plevneliev former President of Bulgaria (PRNewsfoto/IMPROVATE). By IMPROVATE...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 27 | -54% | N/A |
#2 | $4.6M | 27 | 42% | N/A |
#3 | $3M | 27 | 59% | N/A |
#4 | $6.8M | 27 | -4% | N/A |
#5 | N/A | 27 | 29% | N/A |